These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1450 related items for PubMed ID: 26043748

  • 41. Prognostic Value of Preoperative Serum Levels of Five Tumor Markers (Carcinoembryonic Antigen, CA19-9, Alpha-fetoprotein, CA72-4, and CA125) in Gastric Cancer.
    Kim JH, Jun KH, Jung H, Park IS, Chin HM.
    Hepatogastroenterology; 2014 May; 61(131):863-9. PubMed ID: 26176088
    [Abstract] [Full Text] [Related]

  • 42. Expression of annexin a5 is associated with higher tumor stage and poor prognosis in colorectal adenocarcinomas.
    Xue G, Hao LQ, Ding FX, Mei Q, Huang JJ, Fu CG, Yan HL, Sun SH.
    J Clin Gastroenterol; 2009 Oct; 43(9):831-7. PubMed ID: 19461527
    [Abstract] [Full Text] [Related]

  • 43. Prognostic significance of PAK4 expression in gastric cancer.
    Kobayashi K, Inokuchi M, Takagi Y, Otsuki S, Fujimori Y, Sato Y, Yanaka Y, Higuchi K, Aburatani T, Tomii C, Uetake H, Kojima K, Kawano T.
    J Clin Pathol; 2016 Jul; 69(7):580-5. PubMed ID: 26614788
    [Abstract] [Full Text] [Related]

  • 44. Activation of the sonic hedgehog pathway and its prognostic impact in patients with gastric cancer.
    Saze Z, Terashima M, Kogure M, Ohsuka F, Suzuki H, Gotoh M.
    Dig Surg; 2012 Jul; 29(2):115-23. PubMed ID: 22456124
    [Abstract] [Full Text] [Related]

  • 45. CYP24A1 is a potential biomarker for the progression and prognosis of human colorectal cancer.
    Sun H, Wang C, Hao M, Sun R, Wang Y, Liu T, Cong X, Liu Y.
    Hum Pathol; 2016 Apr; 50():101-8. PubMed ID: 26997443
    [Abstract] [Full Text] [Related]

  • 46. Overexpression of EGFR as an Independent Prognostic Factor in Adenocarcinoma of the Esophagogastric Junction.
    Aratani K, Komatsu S, Ichikawa D, Ohashi T, Miyamae M, Okajima W, Imamura T, Kiuchi J, Nishibeppu K, Kosuga T, Konishi H, Shiozaki A, Fujiwara H, Okamoto K, Tsuda H, Otsuji E.
    Anticancer Res; 2017 Jun; 37(6):3129-3135. PubMed ID: 28551654
    [Abstract] [Full Text] [Related]

  • 47. Association of miR-193b down-regulation and miR-196a up-regulation with clinicopathological features and prognosis in gastric cancer.
    Mu YP, Tang S, Sun WJ, Gao WM, Wang M, Su XL.
    Asian Pac J Cancer Prev; 2014 Jun; 15(20):8893-900. PubMed ID: 25374225
    [Abstract] [Full Text] [Related]

  • 48. Multivariate prognostic study on node-positive gastric cancer: is tumor size a prognostic indicator?
    Liu Y, Chen XH, Meng XH, Liu CF, Zhao LL, Han JW, Zhuang LW.
    Hepatogastroenterology; 2012 Jun; 59(114):623-6. PubMed ID: 22024039
    [Abstract] [Full Text] [Related]

  • 49. Increased MACC1 expression indicates a poor prognosis independent of MET expression in gastric adenocarcinoma.
    Koh YW, Hur H, Lee D.
    Pathol Res Pract; 2016 Feb; 212(2):93-100. PubMed ID: 26719224
    [Abstract] [Full Text] [Related]

  • 50. Node-extranodal soft tissue stage based on extranodal metastasis is associated with poor prognosis of patients with gastric cancer.
    Jiang N, Deng JY, Ding XW, Ke B, Liu N, Liang H.
    J Surg Res; 2014 Nov; 192(1):90-7. PubMed ID: 24953988
    [Abstract] [Full Text] [Related]

  • 51. Overexpression of Ras-GTPase-activating protein SH3 domain-binding protein 1 correlates with poor prognosis in gastric cancer patients.
    Min L, Ruan Y, Shen Z, Jia D, Wang X, Zhao J, Sun Y, Gu J.
    Histopathology; 2015 Nov; 67(5):677-88. PubMed ID: 25809930
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Factors associated with early recurrence after curative surgery for gastric cancer.
    Kang WM, Meng QB, Yu JC, Ma ZQ, Li ZT.
    World J Gastroenterol; 2015 May 21; 21(19):5934-40. PubMed ID: 26019458
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Prognostic value of mixed lineage kinase domain-like protein expression in the survival of patients with gastric caner.
    Ertao Z, Jianhui C, Kang W, Zhijun Y, Hui W, Chuangqi C, Changjiang Q, Sile C, Yulong H, Shirong C.
    Tumour Biol; 2016 Oct 21; 37(10):13679-13685. PubMed ID: 27473085
    [Abstract] [Full Text] [Related]

  • 56. Prognostic significance of insulin-like growth factor II mRNA-binding protein 3 expression in gastric adenocarcinoma.
    Jeng YM, Wang TH, Lu SH, Yuan RH, Hsu HC.
    Br J Surg; 2009 Jan 21; 96(1):66-73. PubMed ID: 19109797
    [Abstract] [Full Text] [Related]

  • 57. Detection of circulating gastric cancer cells in peripheral blood using real time quantitative RT-PCR.
    Koga T, Tokunaga E, Sumiyoshi Y, Oki E, Oda S, Takahashi I, Kakeji Y, Baba H, Maehara Y.
    Hepatogastroenterology; 2008 Jan 21; 55(84):1131-5. PubMed ID: 18705345
    [Abstract] [Full Text] [Related]

  • 58. Significant prognostic factors in patients with early gastric cancer.
    Yokota T, Kunii Y, Teshima S, Yamada Y, Saito T, Takahashi M, Kikuchi S, Yamauchi H.
    Int Surg; 2000 Jan 21; 85(4):286-90. PubMed ID: 11589593
    [Abstract] [Full Text] [Related]

  • 59. Prediction of sites of recurrence in gastric carcinoma using immunohistochemical parameters.
    Saito H, Osaki T, Murakami D, Sakamoto T, Kanaji S, Ohro S, Tatebe S, Tsujitani S, Ikeguchi M.
    J Surg Oncol; 2007 Feb 01; 95(2):123-8. PubMed ID: 17262742
    [Abstract] [Full Text] [Related]

  • 60. New cancer suppressor gene for colorectal adenocarcinoma: filamin A.
    Tian ZQ, Shi JW, Wang XR, Li Z, Wang GY.
    World J Gastroenterol; 2015 Feb 21; 21(7):2199-205. PubMed ID: 25717257
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 73.